282 results
Page 5 of 15
8-K
EX-99.1
ahfjk7
16 Nov 18
Precipio Announces Third Quarter 2018 Corporate Update Call for Shareholders
4:47pm
8-K
EX-99.1
1p18zj0
14 May 18
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization
4:11pm
8-K
EX-99.1
yv9mbxyrts a0aw
9 Aug 18
Precipio Appoints New Board Member to Replace Departing Director
4:31pm
8-K
EX-99
qrcntxy08t7bzsppnnf0
15 Aug 07
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
hgvq6h 3j
27 Feb 15
Transgenomic Announces Commencement of Public Offering of Common Stock
12:00am
8-K
EX-10.2
k7r95ssg747vs1r 35
6 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
12:00am
8-K
EX-99.1
gaa3k 5aj942b
11 Dec 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
hzhlq swxtoq2
28 Feb 08
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
50w9v87hm
15 May 19
Other Events
4:08pm
8-K
EX-99.1
7uxxkozosxt46
18 Jul 18
Precipio Announces 213% Year-over-Year Revenue Growth in Preliminary Q2-2018 Results
4:50pm
8-K
EX-99.1
l2aa7qruzhynyb30o553
14 Jan 20
Precipio announces shareholder update call to kick off 2020
2:24pm
8-K
EX-99.1
tmhm2f1ofv qw4u9
6 Nov 13
Transgenomic Reports Third Quarter 2013 Financial Results
12:00am
8-K
EX-99.1
u0xmc0zyik96
1 Aug 12
Transgenomic Reports Second Quarter 2012 Financial Results
12:00am
8-K
EX-99.1
ya2aiqsz7wk9q4x390w
12 May 11
Transgenomic Reports First Quarter Financial Results
12:00am
8-K
EX-4.1
ip6 6ko17cn9
4 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
12:00am
8-K
EX-99.1
mvew8uyahl3mx 49
15 Jun 18
Precipio Inc. Announces Adjournment of Annual Meeting of Shareholders
4:33pm
8-K
EX-99.1
96ixd4rh frbm5lq2fm
11 Aug 11
Transgenomic Reports Second Quarter Financial Results
12:00am
8-K
EX-99.1
46lg o9fjvzqp4lc1
26 Sep 19
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
4:43pm